FINWIRES · TerminalLIVE
FINWIRES

Sika Affirms 2026 Outlook as Subdued Market, Currency Headwinds Weigh on Quarterly Sales

-- Sika (SIKA.SW) on Tuesday upheld its 2026 guidance even as first-quarter sales in Swiss francs declined 7% year over year due to foreign-currency impacts in a subdued global construction market.

Net sales of the Swiss specialty chemicals group reached 2.49 billion francs in the three months ended March 31, down from 2.68 billion francs a year ago. Sales beat the FactSet-compiled consensus estimate of 2.45 billion francs.

In local currencies, sales edged up 0.9% thanks to market share gains across all regions. Sales growth in Europe, the Middle East, and Africa accelerated to 3.6% from 0.7% as construction activity gained pace after the winter months. However, sales in the Americas fell 0.8% after a 4.9% rise in the 2025 first quarter, owing to winter storms and economic uncertainty. Asia-Pacific also declined 2.2% due to a double-digit drop in the Chinese construction business.

While Sika flagged muted global market conditions in 2026, including a low single-digit percentage decline, it expects a gradual improvement in momentum for the construction industry after a softer first half. As such, the company maintained its expectations for sales to increase between 1% and 4% in local currencies in 2026, in line with its target of outperforming the market by 3% to 6%. Sika also confirmed its medium-term strategic targets for "sustainable, profitable" growth under the Strategy 2028.

Additionally, Sika made targeted structural adjustments in China and implemented operational improvements in other markets as part of its Fast Forward program, through which it is on course to deliver 80 million francs of savings in 2026 and 150 million francs to 200 million francs annually at full run rate by 2028.

"We are accelerating our investment in product innovation and improving our customer value proposition," Chief Executive Officer Thomas Hasler said. "We are watchful on the impact of events in the Middle East. We expect global market conditions to remain muted in 2026 and we are acting preemptively."

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR